Results for tag: "Pancreatic Kininogenase"

Pancreatic Kininogenase is a type of Endocrine and Metabolic Disorders Drugs used to treat pancreatic disorders. It is a polypeptide hormone that is produced in the pancreas and is involved in the regulation of glucose metabolism. Pancreatic Kininogenase is used to treat diabetes, obesity, and other metabolic disorders. It works by stimulating the release of insulin from the pancreas, which helps to regulate blood sugar levels. It also helps to reduce inflammation and improve the body's ability to absorb nutrients. Pancreatic Kininogenase is available in both oral and injectable forms. It is typically prescribed by a doctor and is available in both generic and brand-name versions. Common side effects include nausea, vomiting, and diarrhea. The Pancreatic Kininogenase market is highly competitive, with many companies offering products. Some of the major players in the market include Novo Nordisk, Sanofi, Eli Lilly, Merck, and Pfizer. Show Less Read more